Actively Recruiting

All Genders
ID04920474

Protocol for a Research Sample Repository for Hematopoietic Cell Transplantation, Other Cellular Therapies and Marrow Toxic Injuries

Led by Center for International Blood and Marrow Transplant Research · Updated on 2023-05-03

99999999

Participants Needed

1

Research Sites

N/A

Total Duration

On this page

AI-Summary

What this Trial Is About

Researchers are establishing a Research Sample Repository to collect blood samples related to histocompatibility and hematopoietic cell transplantation (HCT) or other cellular therapies. This repository supports research aimed at understanding molecular factors affecting transplant outcomes, studying tissue type distributions, and evaluating the success of transplantation and supportive care in marrow toxic injuries. The research includes anonymous studies and aims to facilitate broader scientific investigations in these areas. The repository accepts samples from four main groups: donors of hematopoietic cells or other cellular therapies, cord blood units used in treatment, recipients of hematopoietic cell transplants or cellular therapies, and patients treated for marrow toxic injuries. Samples come from donors who have donated or plan to donate cells, cord blood units infused at treatment centers, transplant or therapy recipients, and marrow toxic injury patients receiving various treatments including supportive care or stem cell transplants. Participants contribute samples that are made available to researchers for various analyses including genomic and biomolecular studies. The primary goal is to provide blood samples for research related to histocompatibility and transplantation outcomes. Participation includes adults and children with or without decision-making capacity. The repository facilitates access to these samples for approved research, supporting studies from multiple centers and investigators over an extended period.

CONDITIONS

Brief Title

Protocol for a Research Sample Repository for Hematopoietic Cell Transplantation, Other Cellular Therapies and Marrow Toxic Injuries

Who Can Participate

All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Donors who have donated or are scheduled to donate hematopoietic cells or cellular therapy products to an allogeneic recipient
  • All donors registered on the National Marrow Donor Program Registry
  • Testable material from cord blood units infused at participating treatment centers
  • All U.S. recipients of allogeneic or autologous hematopoietic cell transplants or cellular therapies
  • Patients treated for marrow toxic injury at centers participating in the Radiation Injury Treatment Network
  • Participants include adults and children with or without decision-making capacity
Not Eligible

You will not qualify if you...

History of severe allergic reactions to study medication Currently pregnant or breastfeeding Recent participation in another clinical trial within the last 30 days Presence of uncontrolled medical conditions that could affect safety

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Sample Collection

Duration - Ongoing during the study period

Participants provide research samples related to hematopoietic cell transplantation, cellular therapies, or marrow toxic injuries.

Visits occur as samples are collected from donors, recipients, or patients depending on treatment schedules

Long-term Monitoring

Duration - Up to study completion in July 2030

Participants are followed over time to observe outcomes related to hematopoietic cell transplantation and cellular therapies through collected samples.

Periodic visits depending on cohort assignment and sample availability

Trial Site Locations

Total: 1 location

1

NMDP Biorepository

New Brighton, Minnesota, United States, 55112

Actively Recruiting

Loading map...

Research Team

A

Ashley Spahn

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

0

Similar Trials

Allogeneic Hematopoietic Stem Cell Transplantation With Low-...

Graft-versus-Host Disease (GVHD)

Actively Recruiting

1 location

Protocol For A Research Database For Hematopoietic Stem Cell...

Autologous Stem Cell Transplantation

Actively Recruiting

2 locations

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here